BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16838613)

  • 1. [Calcium antagonists in the urethral syndrome of women with urinary incontinence and urgency].
    Granados Loarca EA
    Actas Urol Esp; 2006 Apr; 30(4):406-8. PubMed ID: 16838613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo].
    Frenken CW; Nuijten ST
    Fortschr Med; 1984 Mar; 102(12):349-51. PubMed ID: 6370811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results in the treatment of the unstable bladder with Flunarizine.
    Tosto A; Rinnovati A; Rizzo M
    Acta Urol Belg; 1983; 51(3):300-3. PubMed ID: 6624619
    [No Abstract]   [Full Text] [Related]  

  • 4. Flunarizine and cinnarizine-induced parkinsonism: 25 years of de Melo-Souza's syndrome.
    Teive HA; Munhoz RP; Ferraz HB
    Arq Neuropsiquiatr; 2009 Sep; 67(3B):957. PubMed ID: 19838540
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rheologic therapy of peripheral arteriopathies. Personal observations on the use of flunarizin].
    Palleschi M; Marci M; Ceraso C; Passacantilli A; Marin P
    Clin Ter; 1984 Aug; 110(3):215-20. PubMed ID: 6237860
    [No Abstract]   [Full Text] [Related]  

  • 6. Flunarizine, a calcium channel blocker: a new prophylactic drug in migraine.
    Amery WK
    Headache; 1983 Mar; 23(2):70-4. PubMed ID: 6343298
    [No Abstract]   [Full Text] [Related]  

  • 7. Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation.
    Mendenopoulos G; Manafi T; Logothetis I; Bostantjopoulou S
    Cephalalgia; 1985 Mar; 5(1):31-7. PubMed ID: 3886152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomenclature for flunarizine, cinnarizine, and lomerizine.
    Chu MK; Wang SJ
    Cephalalgia; 2020 Mar; 40(3):321-322. PubMed ID: 31955597
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rehabilitative therapy of tinnitus and vertigo].
    Rapaccini A; Pascucci W
    Recenti Prog Med; 2003; 94(7-8):323. PubMed ID: 12868239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Movement disorders and depression due to flunarizine and cinnarizine.
    Micheli FE; Pardal MM; Giannaula R; Gatto M; Parera I; Paradiso G; Torres M; Pikielny R; Pardal J
    Mov Disord; 1989; 4(2):139-46. PubMed ID: 2733706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flunarizine versus pizotifen: a double-blind study in the prophylaxis of migraine.
    Rascol A; Montastruc JL; Rascol O
    Headache; 1986 Feb; 26(2):83-5. PubMed ID: 3514549
    [No Abstract]   [Full Text] [Related]  

  • 12. D2 receptor blockade by flunarizine and cinnarizine explains extrapyramidal side effects. A SPECT study.
    Brücke T; Wöber C; Podreka I; Wöber-Bingöl C; Asenbaum S; Aull S; Wenger S; Ilieva D; Harasko-van der Meer C; Wessely P
    J Cereb Blood Flow Metab; 1995 May; 15(3):513-8. PubMed ID: 7714010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cinnarizine-induced cholestasis.
    Colle I; Reynaert H; Naegels S; Hoorens A; Urbain D
    J Hepatol; 1999 Mar; 30(3):553. PubMed ID: 10190745
    [No Abstract]   [Full Text] [Related]  

  • 14. Iatrogenic parkinsonism: the role of flunarizine and cinnarizine.
    Miguel R; Correia AS; Bugalho P
    J Parkinsons Dis; 2014; 4(4):645-9. PubMed ID: 25125483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists as a peripherally acting labyrinthine suppressant in humans.
    Mangabeira-Albernaz PL
    Acta Otolaryngol Suppl; 1988; 460():99-103. PubMed ID: 3074621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent non-progressive cinnarizine and flunarizine-induced parkinsonism: An under-recognized tardive syndrome in the elderly?
    Calzetti S; Negrotti A
    J Neurol Sci; 2023 Jan; 444():120526. PubMed ID: 36584558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism.
    Negrotti A; Calzetti S
    Mov Disord; 1997 Jan; 12(1):107-10. PubMed ID: 8990063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine.
    Jhang KM; Huang JY; Nfor ON; Tung YC; Ku WY; Lee CT; Liaw YP
    Eur J Clin Pharmacol; 2017 Jul; 73(7):911-916. PubMed ID: 28386684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapyramidal symptoms associated with calcium-channel blockers.
    Daniel JR; Mauro VF
    Ann Pharmacother; 1995 Jan; 29(1):73-5. PubMed ID: 7711350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flunarizine, a calcium channel blocker, in the prophylactic treatment of migraine.
    Diamond S; Schenbaum H
    Headache; 1983 Jan; 23(1):39-42. PubMed ID: 6826350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.